由于测量仪器的灵敏度,生物标志物数据的组合有效设计受到检测限的限制
A combined efficient design for biomarker data subject to a limit of detection due to measuring instrument sensitivity
摘要:
样本池是生物医学研究中广泛接受的采样策略,可用于降低生物标志物研究的成本。即使单次测定的成本不是评价生物标志物的主要限制,合并也可以是一种强大的设计,其基于由于仪器的检测下限(LLOD)而被删失的数据来提高估计效率。然而,在某些情况下,合并设计会严重影响检测限问题。为了结合合并检测试剂盒和单个检测试剂盒的优点,提出了混合设计,即同时采集合并标本和单个标本的样本。我们研究了这些混合设计在估计两个系统的LLOD参数的效率:(1)正态分布的生物标志物与正态分布的测量误差和合并误差;(2)伽马分布的生物标志物与双指数分布的测量误差和合并误差。采用三次试验设计和重复两次试验设计来估计测量误差和合并误差。采用极大似然法估计参数。我们发现,在合理的条件下,简单的单池设计(其中除一个检测试剂盒外的所有检测试剂盒均为随机个体,单个合并检测试剂盒包括剩余标本)非常有效,可推荐用于实际应用。
英文摘要:
Pooling specimens, a well-accepted sampling strategy in biomedical research, can be applied to reduce the cost of studying biomarkers. Even if the cost of a single assay is not a major restriction in evaluating biomarkers, pooling can be a powerful design that increases the efficiency of estimation based on data that is censored due to an instrument's lower limit of detection (LLOD). However, there are situations when the pooling design strongly aggravates the detection limit problem. To combine the benefits of pooled assays and individual assays, hybrid designs that involve taking a sample of both pooled and individual specimens have been proposed. We examine the efficiency of these hybrid designs in estimating parameters of two systems subject to a LLOD: (1) normally distributed biomarker with normally distributed measurement error and pooling error; (2) Gamma distributed biomarker with double exponentially distributed measurement error and pooling error. Three-assay design and two-assay design with replicates are applied to estimate the measurement and pooling error. The Maximum likelihood method is used to estimate the parameters. We found that the simple one-pool design, where all assays but one are random individuals and a single pooled assay includes the remaining specimens, under plausible conditions, is very efficient and can be recommended for practical use.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。